📣 VC round data is live. Check it out!

GE HealthCare Valuation Multiples

Discover GE HealthCare's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like DexCom, Veeva, ResMed, Mindray and more.

GE HealthCare Overview

About GE HealthCare

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).


Founded

1870

HQ

United States

Employees

54.0K

Financials (LTM)

Revenue: $21B
EBITDA: $4B

EV

$37B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

GE HealthCare Financials

GE HealthCare reported last 12-month revenue of $21B and EBITDA of $4B.

In the same LTM period, GE HealthCare generated $8B in gross profit, $4B in EBITDA, and $2B in net income.

Revenue (LTM)


GE HealthCare P&L

In the most recent fiscal year, GE HealthCare reported revenue of $21B and EBITDA of $4B.

GE HealthCare is profitable as of last fiscal year, with gross margin of 40%, EBITDA margin of 18%, and net margin of 10%.

See analyst estimates for GE HealthCare
LTMLast FY202320242025202620272028
Revenue$21B$21B$20B$20B$21B
Gross Profit$8B$8B$8B$8B$8B
Gross Margin40%40%41%42%40%
EBITDA$4B$4B$4B$4B$4B
EBITDA Margin18%18%18%19%18%
EBIT Margin15%15%12%13%13%
Net Profit$2B$2B$2B$2B$2B
Net Margin10%10%8%10%10%
Net Debt-$6B---

Financial data powered by Morningstar, Inc.

GE HealthCare Stock Performance

GE HealthCare has current market cap of $28B, and enterprise value of $37B.

Market Cap Evolution


GE HealthCare's stock price is $61.99.

GE HealthCare share price decreased by 0.6% in the last 30 days, and by 16.3% in the last year.

GE HealthCare has an EPS (earnings per share) of $4.58.

See more trading valuation data for GE HealthCare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$37B$28B-1.1%-0.6%-12.9%-16.3%$4.58

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

GE HealthCare Valuation Multiples

GE HealthCare trades at 1.7x EV/Revenue multiple, and 9.8x EV/EBITDA.

See NTM and 2027E valuation multiples for GE HealthCare

EV / Revenue (LTM)


GE HealthCare Financial Valuation Multiples

As of June 3, 2026, GE HealthCare has market cap of $28B and EV of $37B.

GE HealthCare has a P/E ratio of 13.6x.

LTMLast FY202320242025202620272028
EV/Revenue1.7x1.8x1.9x1.9x1.8x
EV/EBITDA9.8x9.6x10.4x10.0x9.6x
EV/EBIT11.3x11.6x15.0x13.9x13.2x
EV/Gross Profit4.3x4.4x4.6x4.5x4.4x
P/E13.6x13.5x18.0x14.1x13.5x
EV/FCF24.4x24.3x21.3x23.6x24.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified GE HealthCare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

GE HealthCare Margins & Growth Rates

GE HealthCare grew revenue by 6% and EBITDA by 2% in the last fiscal year.

In the most recent fiscal year, GE HealthCare reported gross margin of 40%, EBITDA margin of 18%, and net margin of 10%.

See estimated margins and future growth rates for GE HealthCare

GE HealthCare Margins

Last FY202420252026202720282029
Gross Margin40%42%40%40%
EBITDA Margin18%19%18%18%
EBIT Margin15%13%13%15%
Net Margin10%10%10%9%
FCF Margin7%8%7%7%

GE HealthCare Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth6%1%5%6%
Gross Profit Growth5%4%1%5%
EBITDA Growth2%4%3%2%
EBIT Growth6%8%5%21%
Net Profit Growth(2%)27%5%(2%)
FCF Growth(2%)(10%)(3%)(2%)

Data powered by FactSet, Inc. and Morningstar, Inc.

GE HealthCare Operational KPIs

GE HealthCare's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

GE HealthCare's Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

GE HealthCare's Rule of X is 32% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for GE HealthCare
LTMLast FY202320242025202620272028
Rule of 4023%23%---
Bessemer Rule of X31%32%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.1M---
R&D Expenses to Revenue6%6%6%7%6%
Opex to Revenue-27%28%28%27%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

GE HealthCare Competitors

GE HealthCare competitors include DexCom, Veeva, ResMed, Mindray, IQVIA, Natera, Philips, Alcon, Illumina and Halma.

Most GE HealthCare public comparables operate across Medical Devices, Medical Imaging & Diagnostics, Healthcare Software, BioTech, HealthTech, B2B SaaS, Vertical SaaS and Longevity.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
DexCom5.9x5.6x20.1x18.6x
Veeva7.3x7.0x16.1x15.5x
ResMed5.0x4.6x13.3x11.8x
Mindray4.8x4.7x14.1x14.4x
IQVIA2.7x2.6x11.6x11.4x
Natera12.8x11.8x(134.3x)(126.2x)
Philips1.5x1.5x8.9x8.8x
Alcon3.4x3.3x13.1x12.9x

This data is available for Pro users. Sign up to see all GE HealthCare competitors and their valuation data.

Start Free Trial

GE HealthCare VC Funding History

Before going public, GE HealthCare raised $5B in total equity funding, across 4 rounds.

Last private valuation of GE HealthCare was $35B, after raising $1B in November 2024.


GE HealthCare Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Nov-24Secondary - public-$1B$35BGE HealthCare Technologies is a public company (NASDAQ: GEHC) providing medical imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics to healthcare providers globally. It holds a leading market position in diagnostic imaging and patient monitoring with an extensive installed base and focus on innovation in AI-powered solutions and digital tools. No private company transaction, funding round, or investment occurred around July 11, 2024; the company reports as a standalone public entity post its prior GE spin-off. As of recent data, GE HealthCare has a market capitalization of $34.90 billion and enterprise value of $41.88 billion. Annual revenue stands at $19.67 billion, with per-employee revenue of $376,736 across 53,000 employees. The imaging segment, the largest business, generated $2.83 billion in a recent quarter. Enterprise value to sales multiple is 2.10 and EV/EBITDA is 11.40, reflecting current trading metrics. Analyst consensus rates it a Strong Buy with an average price target of $89.00. In 2024, the company forecasted adjusted annual profit of $4.20 to $4.35 per share and established the GE HealthCare Foundation for maternal and fetal health initiatives.
Sep-24Secondary - public-$1B--
Feb-24Secondary - public-$1B--
Jun-23Secondary - public-$2B-GE HealthCare Technologies is not a private company and therefore no private transaction occurred on or near July 6, 2023. The company became publicly listed on NASDAQ in January 2023 following its separation from General Electric. As a publicly traded enterprise, its valuation is determined by market capitalization rather than private funding rounds or transactions. As of March 2026, GE HealthCare trades with a market capitalization of approximately $32-35 billion and generates annual revenue of approximately $19.67 billion. The company is a global leader in medical technology, pharmaceutical diagnostics, and digital solutions, offering products and services in diagnostic imaging, ultrasound, patient care solutions, and radiopharmaceuticals.

Acquisitions by GE HealthCare

GE HealthCare has acquired 20 companies to date.

Last acquisition by GE HealthCare was on November 20th 2025. GE HealthCare acquired Intelerad for $2B (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by GE HealthCare

Intelerad
icometrix
Nihon Medi-Physics Co
Intelligent Ultrasound (clinical AI software unit)
Description
Intelerad Medical Systems is a Montreal-headquartered provider of enterprise imaging platforms for radiology and cardiology. Its IntelePACS supports viewing of 10 million studies monthly across 1,000 sites globally. The suite includes InteleOrchestrator for workflow automation, InteleArchive for VNA storage, and InteleHeart for cardiac analytics. Intelerad integrates AI via InteleGence with tools from Aidoc and Viz.ai. Founded in 2001, it serves US hospitals like Cleveland Clinic and teleradiology networks in Europe.
icometrix analyzes brain MRI scans to deliver standardized measurements for neurological disorders like multiple sclerosis, Alzheimer's, and stroke. Their MSmetrix software quantifies lesions, brain atrophy, and gray matter volume, approved in the EU, Canada, Brazil, and Australia with FDA clearance pending. Leuven-headquartered with a Boston office, icometrix founded in 2011 processes images for clinical trials and routine care, holding ISO 9001, 13485, and 27001 certifications.
Nihon Medi-Physics Co. is a Tokyo-headquartered producer of radiopharmaceuticals for diagnostic imaging in nuclear medicine. The company manufactures positron emission tomography agents such as fluorine-18 fluorodeoxyglucose and carbon-11 methionine, alongside single photon emission computed tomography tracers like technetium-99m compounds. These products supply hospitals and research institutions throughout Japan for oncology, neurology, and cardiology scans.
Intelligent Ultrasound's clinical AI software unit develops AI-based image analysis tools that deliver real-time guidance to clinicians during ultrasound scans. The unit focuses on products such as ScanNav Anatomy and ScanNav Fetal, which assist in identifying anatomical structures and reducing scan times. These solutions integrate with existing ultrasound systems from manufacturers like GE Healthcare and Philips. Based in Cardiff, Wales, the unit operates as part of Intelligent Ultrasound Group plc, a medical technology firm listed on the London Stock Exchange's AIM market. Its software enhances diagnostic accuracy in obstetrics, cardiology, and vascular imaging, supporting point-of-care ultrasound in hospitals across Europe and North America.
HQ CountryCanadaBelgiumJapanUnited Kingdom
HQ City
Montreal
Leuven
Tokyo
Oxford
Deal Date20 Nov 202510 Sep 20253 Dec 202418 Jul 2024
Valuation$2Bundisclosedundisclosed$51M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all GE HealthCare acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by GE HealthCare

GE HealthCare has invested in 9 companies to date.

Latest investment by GE HealthCare was on October 6th 2025. GE HealthCare invested in Mediview XR in their $24M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by GE HealthCare

Mediview XR
Laza Medical
Nucleus RadioPharma
Mediview XR
Description
MediView XR is a Minneapolis-headquartered medtech firm specializing in augmented and mixed reality platforms for interventional radiology and oncology procedures. The OmnifyXR suite overlays 3D CT and MRI scans onto live fluoroscopy views from standard X-ray systems, supporting needle guidance and tumor ablation. MediView XR enables remote specialist collaboration via cloud connectivity and integrates with systems from Siemens Healthineers and GE Healthcare for real-time procedural enhancements.
Laza Medical is a Boston-based medtech startup developing the LazaBot, an AI-driven robotic system for real-time 3D imaging during cardiovascular procedures like TAVR and mitral repair. The platform combines fluoroscopy with ultrasound for enhanced visualization, reducing procedure times and radiation exposure. Founded in 2021, the company has secured FDA Breakthrough Device Designation and collaborates with leading cardiac centers for clinical validation.
-
MediView XR is a Minneapolis-headquartered medtech firm specializing in augmented and mixed reality platforms for interventional radiology and oncology procedures. The OmnifyXR suite overlays 3D CT and MRI scans onto live fluoroscopy views from standard X-ray systems, supporting needle guidance and tumor ablation. MediView XR enables remote specialist collaboration via cloud connectivity and integrates with systems from Siemens Healthineers and GE Healthcare for real-time procedural enhancements.
HQ CountryUnited StatesSwitzerlandUnited StatesUnited States
HQ City
Cleveland, OH
Zurich
-
Cleveland, OH
Deal Date6 Oct 202512 Dec 202317 Oct 202316 May 2023
RoundSeries ASeries ASeries ASeries A
Raised$24M$36M$56M$15M
InvestorsCleveland Clinic; EdGE; GE HealthCare; JobsOhio; Mayo ClinicDara Holdings; GE HealthCare; PA MedTech VC Fund; Page One Ventures; The Capital Partnership; Unorthodox VenturesEcho Global Logistics; Eclipse Ventures; Fox Chase Cancer Center; GE HealthCare; Granger Management LLC; Mayo Clinic; Mercy Health; University of MissouriCleveland Clinic; GE HealthCare; Inside View Investments; JobsOhio; Mayo Clinic
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all GE HealthCare investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About GE HealthCare

When was GE HealthCare founded?GE HealthCare was founded in 1870.
Where is GE HealthCare headquartered?GE HealthCare is headquartered in United States.
How many employees does GE HealthCare have?As of today, GE HealthCare has over 54K employees.
Who is the CEO of GE HealthCare?GE HealthCare's CEO is Peter J. Arduini.
Is GE HealthCare publicly listed?Yes, GE HealthCare is a public company listed on Nasdaq.
What is the stock symbol of GE HealthCare?GE HealthCare trades under GEHC ticker.
When did GE HealthCare go public?GE HealthCare went public in 2022.
Who are competitors of GE HealthCare?GE HealthCare main competitors include DexCom, Veeva, ResMed, Mindray, IQVIA, Natera, Philips, Alcon, Illumina, Halma.
What is the current market cap of GE HealthCare?GE HealthCare's current market cap is $28B.
What is the current revenue of GE HealthCare?GE HealthCare's last 12 months revenue is $21B.
What is the current revenue growth of GE HealthCare?GE HealthCare revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of GE HealthCare?Current revenue multiple of GE HealthCare is 1.7x.
What is the current EBITDA of GE HealthCare?GE HealthCare's last 12 months EBITDA is $4B.
What is GE HealthCare's EBITDA margin?GE HealthCare's last 12 months EBITDA margin is 18%.
What is the current EV/EBITDA multiple of GE HealthCare?Current EBITDA multiple of GE HealthCare is 9.8x.
What is the current FCF of GE HealthCare?GE HealthCare's last 12 months FCF is $1B.
What is GE HealthCare's FCF margin?GE HealthCare's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of GE HealthCare?Current FCF multiple of GE HealthCare is 24.4x.
How many companies GE HealthCare has acquired to date?As of June 2026, GE HealthCare has acquired 20 companies.
What was the largest acquisition by GE HealthCare?$2B acquisition of Intelerad on 20th November 2025 was the largest M&A GE HealthCare has done to date.
What companies GE HealthCare acquired?GE HealthCare acquired Intelerad, BK Medical, Caption Health, Intelligent Ultrasound (clinical AI software unit), Puridify, icometrix, Omnyx LLC, Zionexa, Imactis, The Camden Group, and 10 other companies.
In how many companies GE HealthCare has invested to date?As of June 2026, GE HealthCare has invested in 9 companies.
What was the last GE HealthCare investment?On 6th October 2025 GE HealthCare invested in Mediview XR, participating in a $24M Series A round, alongside Cleveland Clinic, EdGE, JobsOhio, and Mayo Clinic.
In what companies GE HealthCare invested in?GE HealthCare invested in CMR Surgical, InSightec, Nucleus RadioPharma, Laza Medical, Centerline Biomedical, Mediview XR, Adavium, Decisio Health, and OhMD.

See public comps similar to GE HealthCare

Lists including GE HealthCare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial